ArticleMolecular therapy : the journal of the American Society of Gene Therapy2024

MiR126-targeted-nanoparticles combined with PI3K/AKT inhibitor as a new strategy to overcome melanoma resistance.

Maria Beatrice Arasi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.